The European Union, Canada and other developed countries have signed deals to get hundreds of millions of doses of Covid-19 vaccines and boosters over the next two years, furthering a divide between rich and poor countries.
Under the recent deals, Pfizer Inc. and BioNTech SE agreed to supply the European Union up to 1.8 billion doses of their vaccine through 2023, while agreeing to supply Canada up to 125 million doses.
Australia, Switzerland and Israel, meanwhile, are set to get Moderna Inc.’s shot through next year, and Switzerland has options for doses in 2023.
The agreements will ensure the countries, including some that failed to lock up sufficient supplies of the mRNA vaccines earlier this year, have enough supplies to inoculate residents and protect them against potentially elusive variants, while providing a sales windfall to the manufacturers.
Yet the deals once again leave out developing countries, many of which have fallen behind in vaccinating residents and struggled to contain the spread of the virus.